SILVER NANOPARTICLES AS ANTIVIRAL-A MINI REVIEW
Downloads
Objective: There are many different species that nanoparticles can suppress, such as bacteria, algae, fungus, archaea, and a vast class of viruses. Method: The method of action involves preventing the creation of the cell membrane or its function, interfering with energy transmission, generating harmful reactive oxygen species (ROS), and preventing or lowering the synthesis of RNA and DNA. Results: Numerous nanomaterials, including those based on silicon, carbon, and metals, as well as nanoarchitectures, have been effectively employed to combat various viruses. The solid-state activity of these nanoarchitecture-based virucidal materials (also known as nano-antivirals) has been firmly supported by recent research. The development of many items, including high-touch surfaces and fabric, benefits greatly from their use. Novelty: The development of scalable and sustainable nano-antiviral products with contact-killing capabilities is recommended in this study, which carefully and critically evaluates current developments in the use of nanomaterials to block the effectiveness of Rotavirus, one of the enteroviruses that kill children.
M. Hassanpour, A. Tazarghi, A. Teimoori, A. Tabaraei, V. Erfani-Moghadam, A. Yamchi, S. Akhondi, and H. Razavi Nikoo, “Curcumin Inhibits the Replication of Rotavirus in Vitro,” Acta Virologica, vol. 66, no. 2, 2022.
Centers for Disease Control and Prevention, “Rotavirus,” CDC, 2021.
M. J. Tohmé and L. R. Delgui, “Advances in the Development of Antiviral Compounds for Rotavirus Infections,” mBio, vol. 12, no. 3, p. e01028-21, 2021.
S. Modrow, D. Falke, U. Truyen, and H. Schätzl, Molecular Virology, Springer, Berlin Heidelberg, Germany, 2013.
M. M. Alam, S. B. Pun, P. Gauchan, M. Yokoo, Y. H. Doan, H. T. Tran, T. Nakagomi, O. Nakagomi, and B. D. Pandey, “The First Identification of Rotavirus B from Children and Adults with Acute Diarrhoea in Kathmandu, Nepal,” Trop. Med. Health, vol. 41, no. 3, pp. 129–134, 2013.
L. Jiang, A. Tang, L. Song, Y. Tong, and H. Fan, “Advances in the Development of Antivirals for Rotavirus Infection,” Front. Immunol., vol. 14, 1041149, 2023.
S. E. Crawford, S. Ramani, J. E. Tate, U. D. Parashar, L. Svensson, M. Hagbom, M. A. Franco, H. B. Greenberg, M. O‘Ryan, and G. Kang, “Rotavirus Infection,” Nat. Rev. Dis. Primers, vol. 3, no. 1, pp. 1–16, 2017.
A. Z. Kapikian and R. E. Shope, “Rotaviruses, Reoviruses, Coltiviruses, and Orbiviruses,” in Medical Microbiology, 4th ed., 1996.
C. Troeger, I. A. Khalil, P. C. Rao, S. Cao, B. F. Blacker, T. Ahmed, G. Armah, J. E. Bines, T. G. Brewer, and D. V. Colombara, “Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea among Children Younger than 5 Years,” JAMA Pediatr., vol. 172, no. 10, pp. 958–965, 2018.
J. E. Tate, A. H. Burton, C. Boschi-Pinto, U. D. Parashar, WHO Global Rotavirus Surveillance Network, M. Agocs, F. Serhan, L. de Oliveira, J. M. Mwenda, and R. Mihigo, “Global, Regional, and National Estimates of Rotavirus Mortality in Children < 5 Years of Age,” Clin. Infect. Dis., vol. 62, suppl. 2, pp. S96–S105, 2016.
M. S. H. Al-Zuheiry, A. A. Al-Duliami, A.-R. S. H. Hasan, and A.-K. Y. Al-Azawi, “The Prevalence of Rotavirus Infection in Baquba-Diyala Province,” Acad. Sci. J., vol. 6, no. 3, pp. 16–27, 2010.
A. A. Hussein, R. A. Hussein, and M. J. Shaker, “Enteric Viruses Co-Infection with Giardiasis among Diarrheal Children in Diyala Province-Iraq,” J. Pure Appl. Microbiol., vol. 12, no. 2, pp. 793–799, 2018.
M. Ayyed, M. F. Al-Dulaim, R. K. Al-Ani, and S. O. G. Al-Mawla, “Incidence of Rota Virus Gastroenteritis among Vaccinated and Non-Vaccinated Children Less than Two Years Old in Ramadi City, Iraq,” Al-Anbar Med. J., vol. 16, no. 1, pp. 8–11, 2020.
S. A. Abd-Al Fattah, M. A. Hamad, and M. Q. Al-Ani, “Prevalence and Molecular Detection of Rotavirus in Children in Ramadi City-Iraq,” Medico Legal Update, vol. 20, no. 4, pp. 2096–2102, 2020.
Y. A. Al-Khafaji and H. J. Al-Jiboury, “Detection of Rotavirus in Diarrhea Stool Samples of Children with Acute Gastroenteritis in Babylon Governorate, Iraq,” Int. Res. J. Microbiol., vol. 4, no. 3, pp. 84–88, 2013.
Q. M. Mutlak, M. K. Abdulridha, and L. M. A. Al-Huseini, “Updates in the Prevalence of Rotavirus Gastroenteritis in Babylon City,” Al Mustansiriyah J. Pharm. Sci., vol. 18, no. 2, pp. 1–12, 2018.
Centers for Disease Control and Prevention, “Transmission of Rotavirus,” CDC, 2021.
A. Bugarcic and J. A. Taylor, “Rotavirus Nonstructural Glycoprotein NSP4 Is Secreted from the Apical Surfaces of Polarized Epithelial Cells,” J. Virol., vol. 80, no. 24, pp. 12343–12349, 2006.
M. Zhang, C. Q.-Y. Zeng, A. P. Morris, and M. K. Estes, “A Functional NSP4 Enterotoxin Peptide Secreted from Rotavirus-Infected Cells,” J. Virol., vol. 74, no. 24, pp. 11663–11670, 2000.
D. Knipe, P. Howley, D. Griffin, R. Lamb, M. Martin, B. Roizman, and S. Straus, Fields Virology, vol. 1–2, Lippincott Williams & Wilkins, Philadelphia, USA, 2013.
S. D. Trask, S. M. McDonald, and J. T. Patton, “Structural Insights into the Coupling of Virion Assembly and Rotavirus Replication,” Nat. Rev. Microbiol., vol. 10, no. 3, pp. 165–177, 2012.
L. Jiang, A. Tang, L. Song, Y. Tong, and H. Fan, “Advances in the Development of Antivirals for Rotavirus Infection,” Front. Immunol., vol. 14, 1041149, 2023.
B. T. Nair, K. G. Bhat, and M. Shantaram, “In Vitro Biofilm Production and Virulence Factors of Uropathogenic Escherichia coli,” Int. J. Pharm. Bio Sci., vol. 4, no. 1, pp. 951–956, 2013.
M. Mehta, “NCMS Study of Nanotechnology in the US Manufacturing Industry,” Natl. Center Manuf. Sci., Ann Arbor, MI, 2014.
T. Deka, M. K. Das, S. Das, L. R. Singha, and P. Das, “Nanobiotechnology and Its Application in Nanomedicine: An Overview,” in Nanomedicine and Nanosafety: Recent Trends and Clinical Evidences, pp. 3–25, 2020.
I. Singh, H. K. Gautam, and G. Dhawan, “Nanobiotechnology: Current and Future Perspectives in Combating Microbial Pathogenesis,” in Pathogenicity and Drug Resistance of Human Pathogens: Mechanisms and Novel Approaches, pp. 337–350, 2019.
J. J. Schwartz, D. S. Jakob, and A. Centrone, “A Guide to Nanoscale IR Spectroscopy: Resonance Enhanced Transduction in Contact and Tapping Mode AFM-IR,” Chem. Soc. Rev., vol. 51, no. 13, pp. 5248–5267, 2022.
B. Javed, M. Ikram, F. Farooq, T. Sultana, Z.-R. Mashwani, and N. I. Raja, “Biogenesis of Silver Nanoparticles to Treat Cancer, Diabetes, and Microbial Infections: A Mechanistic Overview,” Appl. Microbiol. Biotechnol., vol. 105, no. 6, pp. 2261–2275, 2021.
M. A. Islam, M. V. Jacob, and E. Antunes, “A Critical Review on Silver Nanoparticles: From Synthesis and Applications to Its Mitigation through Low-Cost Adsorption by Biochar,” J. Environ. Manage., vol. 281, 111918, 2021.
G. Zhou and W. Wang, “Synthesis of Silver Nanoparticles and Their Antiproliferation against Human Lung Cancer Cells in Vitro,” Orient. J. Chem., vol. 28, no. 2, p. 651, 2012.
N. S. Al-Radadi and A. M. Abu-Dief, “Silver Nanoparticles (AgNPs) as a Metal Nano-Therapy: Possible Mechanisms of Antiviral Action against COVID-19,” 2020.
B. C. Gonçalves, M. G. L. Barbosa, A. P. S. Olak, T. N. Belebecha, L. Nishi, M. A. Watanabe, P. Marinello, D. Z. Rechenchoski, S. D. Rocha, and L. C. Faccin-Galhardi, “Antiviral Therapies: Advances and Perspectives,” Fundam. Clin. Pharmacol., vol. 35, pp. 305–320, 2021.
H. H. Mao and S. Chao, “Advances in Vaccines,” Curr. Appl. Pharm. Biotechnol., vol. 171, pp. 155–188, 2019.
T. A. J. de Souza, L. R. R. Souza, and L. P. Franchi, “Silver Nanoparticles: An Integrated View of Green Synthesis Methods, Transformation in the Environment, and Toxicity,” Ecotoxicol. Environ. Saf., vol. 171, pp. 691–700, 2019.
A. A. Yaqoob, K. Umar, and M. N. M. Ibrahim, “Silver Nanoparticles: Various Methods of Synthesis, Size Affecting Factors and Their Potential Applications—A Review,” Appl. Nanosci., vol. 10, pp. 1369–1378, 2020.
Copyright (c) 2025 Lubna Abdulazem
This work is licensed under a Creative Commons Attribution 4.0 International License.
